Communicating the Value of Influenza Vaccines to Patients: Translating Vaccine Effectiveness to Acceptance

Ann Intern Med. 2023 Dec;176(12):1670-1671. doi: 10.7326/M23-2802. Epub 2023 Nov 28.

Authors

Mark W Tenforde¹, Fatimah S Dawood¹, Sascha R Ellington¹, Lisa A Grohskopf¹, Brendan Flannery¹, Shikha Garg¹, Carrie Reed¹

Affiliation

¹ Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (M.W.T., F.S.D., S.R.E., L.A.G., B.F., S.G., C.R.).

PMID: 38011706
DOI: 10.7326/M23-2802

No abstract available

Publication types

Editorial

MeSH terms

Humans
Influenza Vaccines*
Influenza, Human* / prevention & control
Patient Acceptance of Health Care
Patients
Vaccination
Vaccine Efficacy

Substances

Influenza Vaccines